Hims & Hers Board Investigation for Potential Fiduciary Breaches Amid Novo Nordisk Partnership Termination

viernes, 19 de septiembre de 2025, 2:38 pm ET1 min de lectura
HIMS--
NVO--

Berger Montague is investigating Hims & Hers Health Inc.'s Board of Directors for potential breaches of fiduciary duties in connection with Novo Nordisk's termination of their partnership due to deceptive marketing practices. Shareholders may contact Berger Montague for more information. The law firm has represented investors for over five decades and serves as lead counsel in courts throughout the United States.

Hims & Hers Board Investigation for Potential Fiduciary Breaches Amid Novo Nordisk Partnership Termination

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios